Randomized controlled trial of sodium phosphate tablets vs polyethylene glycol solution for colonoscopy bowel cleansing

Table 1 Demographic data and indication for colonoscopy n (%)

	NaP tables (n = 158)	PEG solution (n = 162)	P value
Mean age (yr)	46.5 ± 9.8	48.6 ± 10.3	0.064
Male	70 (44.3)	69 (42.6)	0.758
BMI	23.2 ± 3.1	23.0 ± 3.0	0.628
Experience of colonoscopy	67 (42.4)	74 (45.7)	0.555
Surgical history	23 (14.6)	35 (21.6)	0.102
Indication for colonoscopy
Screening	89 (56.3)	81 (50.0)	0.257
Bowel habit change	9 (5.7)	17 (10.5)	0.116
Stool caliber change	8 (5.1)	6 (3.7)	0.552
Melena/hematochezia	13 (8.2)	16 (9.9)	0.608
Abdominal pain	22 (13.9)	10 (6.2)	0.021
Anemia	2 (1.3)	2 (1.2)	1.000
Weight loss	1 (0.6)	3 (1.9)	0.623
P/Hx of CRN	13 (8.2)	17 (10.5)	0.487
F/Hx of CRC	0	7 (4.3)	0.015
For polypectomy	1 (0.6)	3 (1.9)	0.623

Values are means ± SD. BMI: Body mass index; P/Hx: Past history; CRN: Colorectal neoplasm; F/Hx: Family history; CRC: Colorectal cancer; PEG: Polyethylene glycol; NaP: Sodium phosphate.